Correction: Ammar et al. Protective Effects of Naringenin from Citrus sinensis (var. Valencia) Peels against CCl4-Induced Hepatic and Renal Injuries in Rats Assessed by Metabolomics, Histological and Biochemical Analyses. Nutrients 2022, 14, 841

In the original publication [...].


Error in Figure
In the original publication [1], there was a mistake in Figures 2 and 3.The authors uploaded the wrong image during the final proofreading.In the original version, Figure 2 displays the micrograph from a section of the kidney.However, Figure 3 displays sections from the liver showing the immunohistochemical expression of Bcl-2 in the hepatocytes.There are duplications in the published Figure 2: Figure 2C,E as well as 2D and 2F are same.Also, there are duplications in the published Figure 3: Figure 3D,E are same.The corrected Figures 2 and 3 appear below.The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected.This correction was approved by the Academic Editor.The original publication has also been updated.

Figure 2 .
Figure 2. Micrograph from a section of the kidney of (A) control rat showing normal structure of renal corpuscle (asterisk) and renal tubules, distal (arrows), and proximal (arrowheads) convoluted tubules; (B) rat given CCl4 showing partially degenerated glomerulus (asterisk).Focal of interstitial hemorrhage is seen (arrows): (C) rat given CCl4 showing necrosis of the renal tubules (arrows).Some renal tubules showed complete degeneration (arrowheads): (D) rat given CCl4 and treated with silymarin showing the renal corpuscle and renal tubules appeared nearly to that of normal control; (E) rat given CCl4 and treated with naringenin (20 mg/kg) showed the renal corpuscle and renal tubules appeared nearly to normal control.Noticed degenerative renal tubules (arrows): (F) rat given CCl4 and treated with naringenin (40 mg/kg) showed the renal corpuscle and renal tubules appeared more or less like normal (H&E, Scale bar: 5 µm).

Figure 2 .
Figure 2. Micrograph from a section of the kidney of (A) control rat showing normal structure of renal corpuscle (asterisk) and renal tubules, distal (arrows), and proximal (arrowheads) convoluted tubules; (B) rat given CCl 4 showing partially degenerated glomerulus (asterisk).Focal of interstitial hemorrhage is seen (arrows): (C) rat given CCl 4 showing necrosis of the renal tubules (arrows).Some renal tubules showed complete degeneration (arrowheads): (D) rat given CCl 4 and treated with silymarin showing the renal corpuscle and renal tubules appeared nearly to that of normal control; (E) rat given CCl 4 and treated with naringenin (20 mg/kg) showed the renal corpuscle and renal tubules appeared nearly to normal control.Noticed degenerative renal tubules (arrows): (F) rat given CCl 4 and treated with naringenin (40 mg/kg) showed the renal corpuscle and renal tubules appeared more or less like normal (H&E, Scale bar: 5 µm).

Figure 3 .
Figure 3.Sections from liver showing immunohistochemical expression of Bcl−2 in the hepatocytes of (A) control rats.Positively stained hepatocytes are contrasted with nonstaining nuclei; (B) positive control rat exhibit negatively stained hepatocytes are contrasted with nonstaining nuclei; (C) rat treated with silymarin drug indicated more positively stained hepatocytes are contrasted with nonstaining nuclei; (D) rat treated with 20 mg/kg of naringenin.Positively stained hepatocytes are contrasted with nonstaining nuclei: (E) rat treated with 40 mg/kg of naringenin, positively stained hepatocytes appearing contrasted with nonstaining nuclei (Immunohistochemical expression of Bcl−2, Scale bar: µm).

Figure 3 .
Figure 3.Sections from liver showing immunohistochemical expression of Bcl−2 in the hepatocytes of (A) control rats.Positively stained hepatocytes are contrasted with nonstaining nuclei; (B) positive control rat exhibit negatively stained hepatocytes are contrasted with nonstaining nuclei; (C) rat treated with silymarin drug indicated more positively stained hepatocytes are contrasted with nonstaining nuclei; (D) rat treated with 20 mg/kg of naringenin.Positively stained hepatocytes are contrasted with nonstaining nuclei: (E) rat treated with 40 mg/kg of naringenin, positively stained hepatocytes appearing contrasted with nonstaining nuclei (Immunohistochemical expression of Bcl−2, Scale bar: µm).